Answer
Severe hypocalcaemia during zoledronic acid 4 mg treatment can cause cardiac arrhythmias and neurological adverse events including convulsions, hypoaesthesia and tetany, may require hospitalisation and can be life-threatening.
Sources for this answer
- Zoledronic acid 4 mg/5 ml concentrate for solution for infusionTillomed Laboratories Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked